Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. (Q43639670)
Jump to navigation
Jump to search
scientific article published on 11 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. |
scientific article published on 11 September 2012 |
Statements
Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome (English)
L Sokol
L Cripe
H Kantarjian
M A Sekeres
S Parmar
P Greenberg
S L Goldberg
V Bhushan
J Shammo
R Hohl
A Verma
G Garcia-Manero
Y-P Li
A Lowe
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference